Table 2.

HIV-RNA plasma levels (copies/mL) at all study time points in study participants

	Stratum	Day 0	Day 1	Day 4	Day 14	Day 28	Day 56	Day 70
Placebo	1	< 50	< 50	< 50	< 50	< 50	< 50
rhIL-7 3 μg/kg	1	< 50	< 50	< 50	< 50	< 50
rhIL-7 3 μg/kg	1	207*	< 50	< 50	433	< 50
rhIL-7 3 μg/kg	1	< 50		< 50		< 50
Placebo†	2	306	206	209	421	963	627
rhIL-7 3 μg/kg†	2	87	< 50	< 50	< 50	52
rhIL-7 3 μg/kg†	2	1300	2640		1440	1660
rhIL-7 3 μg/kg†	2	9665	21200	17100	49	4220
Placebo	1	< 50	< 50	< 50	< 50	< 50
rhIL-7 10 μg/kg	1	< 50	< 50	73	< 50	< 50
rhIL-7 10 μg/kg	1	< 50	< 50	< 50	< 50	< 50
rhIL-7 10 μg/kg	1	< 50	< 50	125	101	96
Placebo†	2	1038	946	673	843	1590
rhIL-7 10 μg/kg†	2	< 50	< 50	56	141	< 50
rhIL-7 10 μg/kg†	2	2615	1690	1080	435	435
rhIL-7 10 μg/kg†	2	2184.5	< 50	< 50	< 50	< 50
Placebo	1	< 50	< 50	< 50	< 50	< 50
rhIL-7 30 μg/kg	1	< 50	< 50	83	< 50	< 50	< 50
rhIL-7 30 μg/kg	1	< 50	< 50	79	< 50	< 50
rhIL-7 30 μg/kg	1	< 50	< 50	154	< 50	61		< 50
Placebo	1	< 50	< 50	<50	< 50	< 50
rhIL-7 60 μg/kg	1	< 50	< 50		< 50	< 50	< 50
rhIL-7 60 μg/kg	1	< 50	< 50	66	< 50	< 50
rhIL-7 60 μg/kg	1	< 50	< 50	< 50	< 50	< 50

Numbers in bold represent plasma HIV-RNA levels above detection from subjects with HIV-RNA less than 50 copies/mL on day 0.

^*Stratum 1 subject with HIV-RNA less than 50 copies/mL at screening but 207 copies/mL on day 0.

^†Participants with HIV-RNA above the limit of detection at screening (stratum 2).